CSIMarket
 
Yield10 Bioscience, Inc.  (MBLX)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 12
 Employees 68
 Revenues (TTM) (Millions $) 1
 Net Income (TTM) (Millions $) -9
 Cash Flow (TTM) (Millions $) 11
 Capital Exp. (TTM) (Millions $) 0

Yield10 Bioscience, Inc.
Metabolix is an advanced biomaterials company focused on delivering sustainable solutions to the plastics industry. We have core capabilities in microbial genetics, fermentation process engineering, chemical engineering, polymer science, plant genetics and botanical science, and we have assembled these capabilities in a way that has allowed us to integrate our biotechnology research with real world chemical engineering and industrial practice. In addition, we have created an extensive intellectual property portfolio to protect our innovations which, together with our technology, serves as a valuable foundation for our business.
Metabolix was formed to leverage the ability of natural systems to produce complex biopolymers from renewable resources. We have focused on a family of biopolymers found in nature called polyhydroxyalkanoates (“PHAs”), which occur naturally in living organisms and are chemically similar to polyesters. We have demonstrated the production of our PHAs from pilot to industrial scale and we have sold our PHA products commercially since 2012.
Our targeted markets offer substantial opportunity for innovation and value creation. Our strategy is based on the performance and differentiation of our materials. We aim to address unmet needs of our customers and leverage the distinctive properties of our proprietary PHA biopolymers to improve critical product qualities of material systems and enable our customers to enhance the value of their products and/or achieve cost savings through their value chains. As such, we are positioning our biopolymers as advanced specialty materials that offer a broad and attractive range of product and processing properties compared to other bioplastics or performance additives. We believe that a substantial global market opportunity exists to develop and commercialize our advanced biopolymer product technology.


MBLX is expected to report next financial results on November 14, 2019.
 

Yield10 Bioscience's Segments
 
 
  Company Estimates  
  Revenue Outlook
Yield10 Bioscience does not provide revenue guidance.

Earnings Outlook
Yield10 Bioscience, Inc. does not provide earnings estimates.

 
Geographic Revenue Dispersion

Takung Art Co., Ltd.

Logged a Loss, Topline Tumbles

In the second quarter Takung Art Co., Ltd lost money of $-0.10 per share compare to $-0.10 a year ago and increased losses from $-0.06 per share from the previous quarter.

Sales fell sharply by -83.76 % to $0.63 millions from $3.85 millions in the same quarter a year ago and sequentially Sales improved by 16.87 % from $0.54 millions.

Inrad Optics, Inc.

Losses Widen, Sales Lower

Lower revenues led to losses in the second quarter, Sales fell by -3.81 % to $2.62 millions and loss per share was at $-0.02 compare to $0.00 per share realized in quarter a year ago.

General Steel Holdings Inc

Losses Widen but Revenues Unchanged

In the second quarter General Steel Holdings Inc increased losses of $-0.08 per share compare to $-0.03 a year ago and increased losses from $-0.02 per share from the previous quarter.

Sales remained unchanged to $0.18 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.

New Frontier Corp

Sales and Earnings Unchanged

In the second quarter New Frontier Corp eps of $0.06 per share compare to $0.00 a year ago and eps remained unchanged from $0.06 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.

Bioanalytical Systems Inc

Deficit Bigger Than a Year Ago, Sales very Strong

In the third quarter Bioanalytical Systems Inc losses widen of $-0.04 per share compare to $-0.01 a year ago and improved from $-0.06 per share from the previous quarter.

Sales grew strongly by 79.85 % to $10.86 millions from $6.04 millions in the same quarter a year ago and sequentially Sales improved by 16.24 % from $9.34 millions.






   
Major Competitors Stock performance

5 Days Decrease / Increase
     
• View Complete Report
   



             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

JBCT's Profile

Stock Price

JBCT's Financials

Business Description

Fundamentals

Charts & Quotes

JBCT's News

Suppliers

JBCT's Competitors

Customers & Markets

Economic Indicators

JBCT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071